Background. Currently, the association between human immunodeficiency virus (HIV) infection and subsequent development of autoimmune hemolytic anemia (AIHA) remains unclear. This nationwide population-based cohort study aimed to determine the association between incident AIHA and HIV infection in Taiwan.
Autoimmune hemolytic anemia (AIHA) is a rare disease, defined as the increased destruction of red blood cells (RBCs) in the presence of anti-RBC autoantibodies [1] . Although the underlying mechanism for the development of AIHA remains largely unclear, it has been reported that infections can induce its development [2] .
When human immunodeficiency virus (HIV) infects a host, it may induce production of autoantibodies, owing to the structural antigen similarity between the viral proteins and self-antigens [3] . A prior report showed that up to 34% of HIV-infected patients have a positive result of a direct antiglobulin test [4] . Previous case reports also found that typical warm antibodies can be detected in HIVinfected individuals with hemolytic anemia [5, 6] . Although some reports have shown that HIV infection can induce the production of autoantibodies, the association between HIV infection and subsequent development of AIHA has not been extensively studied.
Highly active antiretroviral therapy (HAART) is imperative for improving outcomes for people living with HIV (PLWH). When PLWH receive HAART, HAART leads to immune restoration and enhances T-cell-mediated immunity. T-cell-mediated immunity has been shown to play a critical role in the development of AIHA [7] , and a previous case study of AIHA occurring among PLWH during treatment with HAART has been reported [6] . However, little is currently known about the association of HAART with the subsequent development of AIHA.
AIHA management should include the identification of specific AIHA risk factors. Therefore, we conducted the present nationwide population-based cohort study in Taiwanese subjects with and those without HIV to determine the associations of HIV infection and HAART with the risk of incident AIHA.
2012. In Taiwan, by law, medical professionals must report all new HIV cases to the Taiwan CDC within 24 hours of diagnosis. All reported HIV cases in Taiwan were diagnosed on the basis of positive results of HIV Western blot or polymerase chain reaction analysis. All HIV-infected individuals in Taiwan have been offered free-of-charge HAART since 1997 [8] . This study was approved by the institutional review board of Kaohsiung Medical University.
Study Subjects
This cohort study linked the Taiwan The control group was selected from the Taiwan National Health Insurance Research Database. In Taiwan, >99% of Taiwanese citizens have been covered by the National Health Program since 1995 [9] . The control group in this study was matched for age, sex, and date of enrollment (±7 days). Eight controls were randomly selected for each PLWH [10, 11] . Controls were excluded if they (1) had been reported to the Taiwan CDC as having HIV infection or (2) had received a diagnostic code for AIHA before inclusion in the study. All PLWH and controls were followed until a diagnosis of AIHA or death or until 31 December 2012. Data on death events were obtained from the death certificate database of Taiwan.
Outcome Variable
The primary outcome was a new diagnosis of AIHA, defined as the presence of the appropriate ICD-9-CM code (283.0) [12] . A person was considered to have new-onset AIHA only if the condition was recorded in an inpatient setting or at ≥3 outpatient visits in Taiwan.
Controlling Variables
The controlling variables included sociodemographic characteristics, comorbidities, HAART, and AIDS status. The sociodemographic factors included income level and urbanization. The income level was calculated from the average monthly income of the insured person and grouped into 3 levels: low (≤19 200 New Taiwan dollars [TW$]), intermediate (TW $19 201 to <TW$40 000), and high (≥TW$40 000). Urbanization was categorized on the basis of residence in an urban area versus a rural area. The comorbidities in the study subjects included diabetes (ICD-9 code 250), chronic kidney disease (ICD-9 codes 580-587), hypertension (ICD-9 codes 401-405), cancer (ICD-9 codes 140-208), and cerebral vascular disease (ICD-9 codes 430-437).
PLWH were considered to have received HAART if they had received HAART before the new onset of AIHA. The classes of HAART included nucleoside reverse transcriptase inhibitors (NRTIs), nonnucleoside reverse transcriptase inhibitors (NNRTIs), and protease inhibitors (PIs).
AIDS status was defined as the presence of a CD4 + T-lymphocyte count of ＜200 cells/mm 3 or any AIDS-defining condition in an individual with HIV infection [13] . In Taiwan, when an individual with a previously reported case of HIV infection develops AIDS, medical professionals are required to notify the Taiwan CDC within 24 hours of the AIDS diagnosis.
Statistical Analysis
First, the demographic data of the study subjects were analyzed. Continuous data are presented as the mean (± SD), and the 2-sample t test was used for comparisons between groups. Categorical data were analyzed by the Pearson χ 2 test where appropriate.
The incidence of AIHA per 100 000 person-years was calculated in patients with and those without HIV infection. The relative hazard of incident AIHA in PLWH was estimated from a Cox proportional hazards model and compared to that for controls.
To determine the association between HIV infection and incident AIHA, Cox proportional hazards models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs), after adjustment for age, sex, and comorbidities. In these models, death was considered as a competing risk event [14] . Moreover, to evaluate the association between HAART and incident AIHA, a time-dependent Cox proportional hazards model was used to identify risk factors for incident AIHA among PLWH. In this model, HAART and AIDS status were regarded as time-dependent covariables [15] , whereas other confounders, such as age, sex, and comorbidities, data on which were collected at baseline, were considered as fixed covariates.
A time-dependent Cox proportional hazards model was also used to determine the associations of the individual HAART classes with incident AIHA among PLWH. Moreover, the effect of individual HAART drugs on the development of incident AIHA was evaluated among PLWH. In these models, individual HAART classes and drugs were regarded as time-dependent covariables. Adjusted HRs with 95% CIs are reported to indicate the strength and direction of the associations.
To examine the interactions between HIV infection and other variables, subgroup analyses were conducted after stratifying the study subjects by age, sex, and comorbidities. All data management and analyses were performed using the SAS 9.4 software package (SAS Institute, Cary, NC).
RESULTS

Participant Selection
A total of 20 351 HIV-infected individuals were reported to the Taiwan CDC from 1 January 2000 through 31 December 2012. We excluded 69 aged <15 years, 8 with antecedent AIHA, and 1222 with incomplete data, and the remaining 19 052 PLWH were included in the analysis (Supplementary Figure 1) . Another 152 416 age-and sex-matched subjects without HIV infection were randomly selected for controls. The mean age (±SD) in each group was 33.4 ± 10.2 years, and 93.1% of PLWH were male. The mean follow-up times (±SD) were 5.08 ± 3.22 years and 5.50 ± 3.15 years among PLWH and controls, respectively. The demographic characteristics and comorbidities of the 2 groups are shown in Table 1 . There were no significant differences in age or sex between the groups. Compared with controls, PLWH had significantly higher proportions of chronic kidney disease, malignancy, and cerebral vascular disease but a significantly lower proportion of diabetes.
AIHA Incidence Rate
During the study follow-up period, 30 individuals developed new-onset AIHA, including 23 PLWH (0.12%) and 7 controls (0.01%). The incidence rate of AIHA was 23.76 events/100 000 person-years among PLWH and 0.84 events/100 000 person-years among controls (P <.001). Compared with controls, the relative hazard of incident AIHA was 26.3 (95% CI, 11.2-61.8) among PLWH. The time to diagnosis of incident AIHA was significantly shorter for PLWH than for controls (P <.001, by the log-rank test; Figure 1 ).
Among 23 PLWH with AIHA, 22 cases (95.7%) occurred during HAART. Among these 22 AIHA cases, the mean time Follow-up duration, years (±SD) to onset of incident AIHA was 1.59 ± 2.61 years from HAART initiation. Table 4 ).
Association of HIV Infection With Incident AIHA
Association of HAART Classes With Incident AIHA Among PLWH
This study evaluated the association of the different classes of HAART with incident AIHA among PLWH. After adjustment for age, sex, and comorbidities, the risk of AIHA was significantly higher among PLWH receiving NRTIs (adjusted HR, 6.19; 95% CI, 1.04-36.9) than among those not receiving NRTIs ( Table 5) .
Association of HAART Drugs With Incident AIHA Among PLWH
Time-dependent Cox proportional hazards models were used to determine the associations between individual HAART (Table 6 ). Among 12 PLWH with AIHA receiving efavirenz treatment, the mean time (±SD) to the onset of incident AIHA was 1.19 ± 2.44 years from last efavirenz use. Furthermore, among 8 PLWH with AIHA receiving atazanavir treatment, the mean time (±SD) to the onset of incident AIHA was 0.38 ± 0.95 years from last atazanavir use.
DISCUSSION
This nationwide cohort study found that, compared with controls, PLWH had a higher risk of developing incident AIHA, after adjustment for demographic data and comorbidities. Moreover, PLWH receiving HAART were more likely to develop AIHA than those not receiving HAART. Additionally, the risk of AIHA was significantly increased among those who received the efavirenz or atazanavir component of HAART.
We found robust associations of HIV infection with incident AIHA after stratifying patients according to age, sex, and comorbidities. HIV infection significantly increased the risk of incident AIHA in all subgroups. This study found that the incidence rates of AIHA were 23.76 and 0.84 events/100 000 person-years in PLWH and controls, respectively. The incidence rate of AIHA among controls was similar to the rate of 0.8 events/100 000 person-years in a prior population-based report from the United States [16] . Although the etiologies of AIHA remain largely unclear, our study found that PLWH had a 28-fold higher risk of AIHA than controls. Our study suggests that clinicians need to be aware of the higher risk of AIHA in this population.
The molecular mimicry between HIV proteins and self-antigens, as well as the loss of immunological tolerance, may explain these higher risks of incident AIHA in PLWH. Molecular mimicry is the prevalent mechanism of AIHA, secondary to various infectious etiologies [7] . The structural antigen similarity between HIV proteins and RBC antigens can induce autoantibody production [17, 18] and might be associated with the development of incident AIHA. Loss of immunological tolerance may also explain the higher risks of incident AIHA among PLWH. When HIV infects the host, it causes the dysregulation of CD4 + T-cell immunity, which could lead to defects in the body's tolerance to self-antigens [19] . Previous report showed that the breakdown of tolerance to self-antigens played a critical role in the development of AIHA [7] . This study found that PLWH receiving HAART were more likely to develop incident AIHA than PLWH not receiving HAART. HAART-induced immune restoration may explain the higher risk of AIHA in those receiving antiretroviral therapy. HAART initiation yields an increased number of CD4 + T-lymphocytes and enhances T-cell-mediated immunity. A recent report showed that T-cell-mediated immunity plays an important role in the development of AIHA [7] . HAART initiation also yields an increased number of T-helper type 17 (Th17) cells, which are characterized by secretion of interleukin 17. A prior report identified Th17 cells as the key effector in the development of AIHA [20] . In a rat model, the adoptive transfer of Th17 cells heightened the anti-RBC antibody responses and accelerated the onset of AIHA, whereas disease onset was abrogated by in vivo neutralization of interleukin 17 [20] .
Although our study showed that PLWH receiving HAART had a relatively high risk of AIHA, we presumed that HAART is a precipitating, rather than fundamental, factor for the development of AIHA. Instead, the molecular mimicry between the HIV proteins and self-antigens and the loss of immunological tolerance may be the direct causes of the development of AIHA. The molecular mimicry between HIV proteins and RBC antigens and the defective tolerance to self-antigens lead to the production of anti-RBC antibodies and may consequently induce the development of AIHA. When PLWH receive HAART, HAART-induced T-cell immunity accelerates the development of AIHA. A previous report showed that autoimmune diseases could be precipitated or exacerbated by HAART-induced T-cell immunity [21] .
In this study, we found that PLWH receiving efavirenz or atazanavir had higher risks of AIHA than those not receiving these drugs. Efavirenz-associated AIHA has been reported in a previous case report [22] , in which a 36-year-old female HIV-infected patient developed immune-mediated hemolytic anemia after receiving HAART, which resolved upon switching the efavirenz component of the HAART to lopinavir/ritonavir [22] . However, additional studies are needed to determine the causal relationship between the individual HAART drugs and the development of AIHA.
This study is the largest cohort study to address the association between HIV infection and subsequent development of AIHA. Our research design, which included unbiased subject selection and strict criteria for the diagnosis of HIV infection, supports the validity of our findings. Moreover, this nationwide population-based study traced all PLWH and controls, with referral bias minimized because all medical care was covered by the Taiwan national health insurance program. Furthermore, the study's large sample size was powered to detect even very small differences between PLWH and controls. Additionally, information regarding the timing of HAART was collected for all patients, and HAART was regarded as a time-dependent variable in the analysis. Longitudinal studies that do not account for changes in exposure during the study period will not be able to precisely estimate the exposure effect on outcomes [23] . The present study nevertheless has some limitations. First, when a new HIV-infected individual was reported to the Taiwan CDC, viral loads and CD4 + T-cell counts-the index of advanced-stage HIV infection-were not required to be entered into the HIV Surveillance System. Only 2516 PLWH (13.2%) had information regarding viral loads and CD4 + T-cell counts at the time of HIV notification. However, the Taiwan CDC requires medical professionals to report HIV-infected individuals' AIDS status-an indicator of immune status-within 24 hours of an AIDS diagnosis. The multivariable analysis in our study controlled for AIDS status among PLWH and treated the AIDS status as a time-dependent variable to mimic the realworld scenario regarding the immune status of HIV-infected individuals. Second, the diagnosis of AIHA, which relied on administrative claims data recorded by physicians or hospitals, may be less accurate than diagnoses made in a prospective clinical setting. However, there is no reason to suspect that the validity of claims data would differ according to the patients' HIV status. This nondifferential misclassification of outcome would bias the results toward a null association. Finally, the external validity of our findings may be a concern, because almost all our enrollees were Taiwanese. The generalizability of our results to other non-Asian ethnic groups requires further verification. However, our findings suggest new avenues for future research.
In summary, this nationwide long-term cohort study found a link between HIV infection and AIHA. HIV infection was an independent risk factor for incident AIHA, after adjustment for demographic data and comorbidities. Compared with PLWH not receiving HAART, PLWH receiving HAART were more likely to develop incident AIHA. Our study suggests that clinicians need to be aware of the higher risk of AIHA in this population.
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